Kingfisher PLC has announced the purchase of 25,000 ordinary shares on 25 February 2026 for cancellation as part of its £300 million share repurchase programme. The volume-weighted average price paid per share was £3.6701, with the highest price at £3.6990 and the lowest at £3.6500. This transaction, conducted with Goldman Sachs International on the London Stock Exchange, brings the total shares purchased for cancellation under the fifth tranche of the programme to 19,038,200.
Kingfisher plc, ISIN: GB0033195214 (the "Company", "Kingfisher") announces that on 25 February 2026 it purchased for cancellation the following number of ordinary shares of 15 5/7 pence each from Goldman Sachs International ("GSI") as part of its £300 million share repurchase programme announced on 25 March 2025 (the "Programme"). All shares were purchased by Kingfisher from GSI as an "on-exchange" transaction subject to the rules of the London Stock Exchange.
Date of Purchase:
25 February 2026
Total number of shares purchased:
25,000
Volume Weighted Average price paid per share:
£3.6701
Highest price paid per share:
£3.6990
Lowest price paid per share:
£3.6500
To date, Kingfisher has purchased 19,038,200 ordinary shares in aggregate for cancellation from GSI in connection with the fifth tranche of the Programme. Kingfisher also previously purchased 17,932,871 ordinary shares in aggregate for cancellation from GSI,18,118,306 ordinary shares in aggregate for cancellation from BNP Paribas SA, 24,713,988 ordinary shares in aggregate for cancellation from GSI and 16,095,884 ordinary shares in aggregate for cancellation from Morgan Stanley & Co. International Plc in connection with its execution of the first, second, third and fourth tranches, respectively, of the Programme.
A schedule of individual trades carried out by GSI as principal in connection with the above purchases is set out below.
Schedule of Purchases - Aggregate Information
Trading Venue
Number of Shares
Volume Weighted Average Price paid per share
XLON
25,000
£3.6701
CHIX
0
£0.0000
BATE
0
£0.0000
TRQX
0
£0.0000
AQXE
0
£0.0000
Schedule of Purchases - Individual Transactions
Price GBP
Time of each trade on 25 Feb 2026 (GMT)
Trading Venue
Number of Shares
Transaction Reference Number
3.6520
08:50:32
XLON
616
1396612307886852
3.6520
08:50:32
XLON
544
1396612307886853
3.6510
08:52:08
XLON
865
1396612307886938
3.6510
08:52:08
XLON
430
1396612307886939
3.6630
09:18:35
XLON
1,023
1396612307888928
3.6600
09:45:30
XLON
984
1396612307890754
3.6580
10:12:11
XLON
1,012
1396612307892482
3.6500
10:46:36
XLON
1,091
1396612307894553
3.6530
11:09:02
XLON
936
1396612307895882
3.6580
11:38:41
XLON
984
1396612307897644
3.6730
12:17:23
XLON
977
1396612307900116
3.6730
12:49:20
XLON
100
1396612307901829
3.6870
13:18:18
XLON
943
1396612307903300
3.6850
13:21:10
XLON
821
1396612307903439
3.6850
13:21:10
XLON
182
1396612307903440
3.6870
13:42:07
XLON
986
1396612307904568
3.6960
14:07:56
XLON
994
1396612307906227
3.6990
14:29:30
XLON
1,123
1396612307908224
3.6910
14:35:40
XLON
1,005
1396612307911253
3.6750
14:46:17
XLON
1,031
1396612307913486
3.6700
14:57:35
XLON
937
1396612307915964
3.6660
15:09:19
XLON
1,103
1396612307918552
3.6640
15:20:52
XLON
988
1396612307920361
3.6640
15:32:25
XLON
918
1396612307922115
3.6690
15:49:20
XLON
952
1396612307924608
3.6720
16:04:57
XLON
931
1396612307927332
3.6740
16:14:12
XLON
958
1396612307929646
3.6720
16:22:28
XLON
932
1396612307932021
3.6700
16:24:31
XLON
634
1396612307932643
Contacts:
Tel:
Email:
Group Company Secretariat
+44 (0) 20 7372 8008
secretariat@kingfisher.com
Investor Relations
+44 (0) 20 7644 1082
investorenquiries@kingfisher.com
Treasury
+44 (0) 20 7372 8008
treasury@kingfisher.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.
